STAAR Surgical Company Recap

What is your opinion of STAAR Surgical Company?

STAAR Surgical Company

NASDAQ:STAA - Nov. 28th 4:00am

$ 8.48 -0.02 (-0.24%)

Shares of STAAR Surgical Company – a $329 million market cap Medical Equipment, Supplies & Distribution company – have fallen -0.24 percent to $8.48 as of 12:00 AM.

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company's principal products are intraocular lenses (IOLs) and implantable Collamer lenses (ICLs). IOLs are prosthetic intraocular lenses used to restore vision that has been adversely affected by cataracts, and include the Company's lines of silicone and Collamer IOLs and the Preloaded Injector (a silicone or acrylic IOL preloaded into a single-use disposable injector). ICLs, consisting of the Company's ICL and Toric implantable collamer lenses (TICL), are intraocular lenses used to correct refractive conditions, such as myopia (near-sightedness), hyperopia (far-sightedness) and astigmatism. The Company operates under the brands STAAR, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX nanoPOINT, Epiphany and AquaFlow. Collamer is the brand name for its collagen copolymer lens material.

Find out more about STAAR Surgical Company.

STAAR Surgical Company Stock Price

STAAR Surgical Company (NASDAQ:STAA) dropped $-0.02 to lose -0.24%.

MONROVIA, CA | 1 day ago

STAAR Surgical Company